Equity Overview
Price & Market Data
Price: $3.76
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $264,236,672
Daily Volume: 0
Performance Metrics
1 Week: -0.53%
1 Month: -0.79%
3 Months: 0.53%
6 Months: 82.52%
1 Year: 238.7%
YTD: 0.53%
Company Details
Employees: 86
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.